protein
fold
er
extraordinarili
challeng
er
must
manag
modifi
polypeptid
present
high
er
lumen
moreov
fold
er
slow
coupl
coval
disulfid
format
transmembran
insert
nglycosyl
nonetheless
er
display
extraordinari
capac
assist
fold
assembl
protein
differ
step
protein
matur
sent
secretori
pathway
anim
cell
secret
protein
transloc
er
cotransl
unfold
nascent
polypeptid
thu
rate
messeng
rna
mrna
translat
influenc
burden
unfold
protein
er
qualiti
control
mechan
exist
monitor
synthesi
protein
synthes
ribosom
alter
rate
translat
exampl
allow
accur
translat
fold
qualiti
mrna
codon
usag
affect
translat
rate
translat
rate
turn
alter
chaperon
bind
nascent
chain
perturb
er
sens
erresid
transmembran
pkr
like
er
kinas
perk
phosphoryl
eukaryot
initi
factor
eif
transient
arrest
translat
thu
decreas
flux
protein
enter
er
perk
activ
part
specif
stress
respons
system
unfold
protein
respons
upr
protect
er
fold
environ
detect
respond
presenc
misfold
protein
lumen
er
hold
vast
repertoir
erresid
chaperon
fold
factor
direct
monitor
errorpron
step
protein
biosynthesi
posttransl
modif
oxid
fold
matur
client
protein
function
tertiari
quaternari
state
er
mani
secretori
protein
undergo
asparaginelink
glycosyl
specif
site
asnxserthr
glycosyl
two
outer
glucos
unit
cotransl
trim
glucosidas
ii
gener
monoglycosyl
asparaginelink
oligosaccharid
recogn
lectinlik
molecular
chaperon
calnexin
calreticulin
releas
chaperon
lead
enzymat
remov
remain
glucos
unit
er
glucosidas
ii
conform
matur
releas
glycoprotein
proteinfold
machineri
coupl
process
product
transport
beyond
er
accumul
andor
aggreg
misfold
protein
degrad
endoplasm
reticulumassoci
degrad
erad
other
escap
er
degrad
instead
lysosom
proteas
erad
misfold
protein
first
recogn
er
cytosol
chaperon
chaperonelik
lectin
glycosyl
protein
process
nglycan
er
mannosidas
act
timer
protein
fate
decis
actual
event
mannos
trim
degrad
er
mannosidas
like
occur
specif
subcompart
er
recent
name
qualiti
control
vesicl
qcv
cisgolgi
region
suggest
substrat
erad
need
reach
golgi
degrad
ubiquitin
protein
retrotransloc
er
cytosol
deliv
proteasom
degrad
hierarchi
qualiti
control
checkpoint
sustain
protein
homeostasi
er
correctli
fold
protein
releas
er
fold
machineri
proceed
along
secretori
pathway
protein
move
forward
follow
call
bulk
flow
simpl
format
vesicl
exit
er
creat
suck
forc
chanc
insert
protein
free
move
vesicl
depart
er
figur
case
concentr
protein
transport
secretori
vesicl
present
er
lumen
protein
instead
move
thank
activ
transport
protein
recogn
specif
cargo
receptor
transport
adaptor
compon
vesicl
coat
figur
factor
activ
chose
bind
cargo
er
insert
form
vesicl
case
protein
transport
concentr
depart
vesicl
interestingli
mechan
er
resid
chaperon
enzym
normal
exclud
depart
vesicl
like
er
fold
factor
exist
supramolecular
complex
import
ensur
effici
fold
one
hand
avoid
escap
enzym
mistak
anoth
hypothesi
action
cargo
select
ensur
exclus
er
resid
protein
er
depart
vesicl
vesicl
exit
er
form
socal
er
exit
site
ere
copii
compon
recruit
protein
adaptor
start
format
vesicl
copii
coat
compos
differ
molecul
small
gtpase
subunit
form
heterodim
subunit
form
heterotetram
transmembran
protein
need
exit
er
normal
directli
interact
coat
compon
interact
mediat
specif
amino
acid
cytosol
tail
allow
specif
recognit
copii
compon
requir
specif
adaptor
case
ampa
receptor
transport
er
fact
mediat
activ
cargo
adaptor
call
cornichon
protein
length
transmembran
domain
tmd
constraint
allow
exit
er
protein
longer
tmd
thu
exclud
depart
vesicl
transmembran
er
resid
enzym
cargo
receptor
identifi
far
secretori
solubl
protein
protein
similar
structur
vipl
ergicl
review
transmembran
protein
bind
cargo
er
thank
lumin
domain
interact
cytosol
tail
copii
compon
interact
cargo
gener
mediat
glycan
recognit
transport
act
lectin
even
major
secret
protein
requir
format
copii
vesicl
nonconvent
secret
case
describ
select
cargo
exit
er
depend
copii
vesicl
copii
coat
multimer
protein
assembl
whose
format
necessari
secret
major
protein
eukaryot
cell
figur
refer
therein
assembl
initi
transmembran
protein
activ
small
gtpase
turn
insert
ntermin
amphipath
helix
er
membran
level
ere
initi
membran
curvatur
recruit
copii
compon
direct
interact
form
heterodim
constitut
inner
part
copii
coat
recogn
specif
transport
signal
transmembran
secretori
protein
protein
adaptor
assembl
complet
recruit
second
layer
compos
heterotetram
interact
occur
anoth
factor
play
import
role
process
er
peripher
membran
protein
local
ere
independ
act
scaffold
copii
assembl
acut
increas
cargo
load
secretori
pathway
often
caus
er
stress
condit
mammalian
cell
show
decreas
number
ere
reduc
format
copii
vesicl
contrari
chronic
rise
cargo
load
induc
increas
size
number
ere
moreov
natur
cargo
also
regul
modifi
gener
copii
vesicl
cargo
stimul
activ
modifi
structur
cage
influenc
geometri
complex
henc
curvatur
vesicl
bud
er
membran
interestingli
recent
describ
copii
machineri
anoth
addit
function
select
interact
protein
need
transport
protein
adaptor
copii
activ
sort
protein
need
proceed
along
secretori
pathway
import
avoid
insert
depart
vesicl
er
resid
chaperon
enzym
misfold
protein
format
vesicl
depart
er
control
activ
requir
ere
homeostasi
control
mapk
signal
rafmek
cascad
activ
growth
factor
fact
activ
phosphoryl
stimul
copii
vesicl
biogenesi
way
growth
factor
stimul
increas
level
er
export
moreov
recent
demonstr
activ
tyrosin
kinas
present
ere
ltk
phosphoryl
thu
activ
start
assembl
copii
coat
figur
ltk
activ
still
unknown
sure
interest
issu
correct
function
effici
transport
secretori
protein
er
crucial
step
protein
homeostasi
along
secretori
pathway
gener
entir
cell
complex
protein
matur
step
impli
exist
sever
machineri
sequenti
distribut
along
secretori
pathway
must
work
properli
protein
reach
nativ
state
correct
final
local
someth
go
wrong
step
protein
abl
result
function
activ
like
lead
patholog
condit
consid
protein
matur
checkpoint
earli
secretori
pathway
er
ere
ergic
distinguish
three
differ
situat
could
caus
diseas
link
traffick
figur
qc
especi
proxim
qc
stringent
case
exampl
cftrthe
protein
fold
abnorm
protein
aggreg
er
ergic
compart
case
mutant
trypsin
protein
traffick
er
golgi
effici
case
mutat
mutat
compon
copii
coat
cystic
fibrosi
cf
common
lethal
monogen
autosom
recess
diseas
among
caucasian
popul
caus
dysfunct
cystic
fibrosi
transmembran
conduct
regul
cftr
glycoprotein
normal
function
chloridebicarbon
channel
apic
membran
epithelia
thu
function
maintain
ion
fluid
homeostasi
human
cftr
belong
atpbind
cassett
abc
transport
superfamili
consist
domain
tmd
form
transloc
pathway
two
cytoplasm
nucleotidebind
domain
nbd
hydrolyz
atp
regulatori
r
domain
must
phosphoryl
allow
channel
open
common
cfcaus
mutat
delet
phenylalanin
present
approxim
cf
patient
caus
cftr
misfold
recogn
er
qualiti
control
system
result
er
retent
target
degrad
ubiquitinproteasom
pathway
sever
consequ
lack
cftr
activ
manifest
pancrea
lung
pancrea
failur
bicarbonaterich
fluid
enzym
secret
impair
intestin
digest
absorpt
lung
defect
transport
thu
fluid
secret
coupl
hyperabsorpt
na
fluid
lead
secret
thick
dehydr
mucu
colon
microorgan
caus
damag
inflammatori
respons
multipl
checkpoint
level
fold
traffick
mutant
suggest
regul
er
retent
exit
fold
checkpoint
involv
interact
chaperon
traffick
checkpoint
involv
recognit
traffickingexit
signal
direct
toward
vesicular
transport
nascent
initi
recogn
machineri
interact
cochaperon
chip
convert
protein
fold
system
proteasom
degrad
factor
mediat
coval
attach
ubiquitin
ubiquitin
ligas
activ
chaperon
substrat
protein
small
fraction
escap
qualiti
control
assess
via
recognit
glycan
moieti
calnexinindepend
mechan
traffick
checkpoint
act
level
recognit
four
threeresidu
argininefram
tripeptid
aft
cftr
function
er
retent
motif
substitut
lysin
one
arginin
four
triplet
simultan
allow
nascent
matur
onethird
increas
function
although
fulli
wildtyp
cftr
level
howev
full
correct
fold
achiev
measur
gate
properti
channel
releas
er
retent
interf
recognit
aft
signal
may
provid
basi
novel
therapeut
strategi
cf
small
molecul
repair
fold
process
defect
cftr
promot
interact
first
cytoplasm
loop
transmembran
domain
first
nucleotidebind
domain
thu
rescu
local
traffick
checkpoint
occur
level
cftr
inclus
copii
vesicl
sort
cftr
vesicl
bud
er
mediat
interact
subunit
copii
highli
conserv
diacid
code
residu
sequenc
dad
cftr
mutat
residu
sever
affect
export
cftr
aspart
residu
replac
alanin
cftr
associ
reduc
fold
affect
replac
aspart
residu
alanin
ddaacftr
block
cftr
exit
er
progress
made
toward
accomplish
goal
effect
cftr
modul
therapi
cftr
modul
includ
among
other
potenti
promot
channel
activ
corrector
promot
cftr
er
exit
traffic
readthrough
agent
restor
fulllength
cftr
suppress
prematur
termin
codon
combin
potenti
corrector
shown
suffici
rescu
cftr
human
bronchial
epitheli
cell
cftr
activ
howev
mani
patient
rare
mutat
yet
impact
cftr
modul
due
unknown
suscept
mutat
treatment
grow
knowledg
molecular
mechan
respons
defect
cftr
suggest
effect
therapi
target
repair
phase
cftr
express
function
member
serin
proteinas
inhibitor
serpin
superfamili
primari
role
inhibit
proteolyt
enzym
elastas
secret
activ
neutrophil
ne
degrad
elastin
within
connect
tissu
thu
maintain
structur
integr
lung
elastin
singledomain
protein
amino
acid
residu
fold
three
sheet
nine
helic
surround
sheet
scaffold
reactiv
center
loop
protrud
main
bodi
molecul
mediat
inhibitori
specif
antitrypsin
bind
coval
target
proteinas
specif
residu
within
rcl
rcl
transloc
proteinas
opposit
end
due
conform
chang
inactiv
proteas
stabil
metast
natur
thu
requir
facilit
rapid
gross
conform
chang
requir
proteinas
inhibit
correct
conform
matur
newli
synthes
polypeptid
prerequisit
product
transport
along
compart
secretori
pathway
biosynthesi
er
subject
qualiti
control
checkpoint
initi
facilit
conform
matur
newli
synthes
sever
natur
occur
genet
variant
identifi
associ
diminish
system
concentr
inhibitor
caus
diseas
inherit
disord
lung
liver
sever
reduc
concentr
ensu
elastolyt
degrad
lung
connect
tissu
increas
risk
develop
chronic
obstruct
pulmonari
diseas
lossoffunct
phenotyp
notabl
main
site
biosynthesi
liver
accumul
mutat
er
hepatocyt
risk
factor
develop
childhood
liver
diseas
gainoftox
function
phenotyp
frequent
diseaseassoci
mutat
includ
point
mutat
gene
name
atz
variant
result
singl
amino
acid
substitut
lead
slowdown
last
step
fold
consequ
increas
intracellular
polymer
accumul
atz
polym
er
hepatocyt
caus
er
stress
low
secret
eventu
endstag
patholog
requir
liver
transplant
intracellular
polym
insolubl
aggreg
mutant
atz
variant
observ
liver
biopsi
specimen
patient
atd
cargo
receptor
describ
cargo
receptor
see
paragraph
like
fail
recogn
misfold
like
polymer
atz
mutant
thu
contribut
accumul
er
accumul
atz
er
associ
markedli
dilat
er
cisterna
larg
vesicl
two
main
pathway
involv
dispos
misfold
atz
proteasom
pathway
autophagi
avoid
er
clog
atz
elimin
secretori
pathway
erassoci
degrad
erad
machineri
target
misfold
protein
cytosol
degrad
proteasom
inde
atz
one
first
identifi
substrat
erad
pathway
autophagi
later
describ
addit
pathway
atz
clearanc
accumul
atz
within
er
ergic
suffici
activ
autophag
respons
demonstr
increas
gfp
autophagosom
liver
autophagosom
report
mous
notabl
autophagyenhanc
drug
promot
atz
clearanc
attenu
hepat
fibrosi
recent
ertolysosom
degrad
pathway
describ
proteasom
resist
atz
aggreg
peculiar
characterist
cellular
respons
er
accumul
atz
lack
signific
activ
unfold
protein
respons
upr
recent
structur
data
provid
explan
solubl
monomer
atz
get
recogn
upr
apparatu
monomer
atz
intermedi
adopt
conform
resembl
wildtyp
molecul
therefor
would
recogn
unfold
gene
express
profil
transgen
mice
induc
express
atz
liver
shown
mark
upregul
regul
g
protein
signal
increas
upon
exposur
classic
induc
er
stress
indic
activ
characterist
specif
atz
accumul
er
furthermor
target
disrupt
heterotrimer
g
protein
mous
model
lead
mark
increas
hepat
insulininduc
autophag
activ
data
indic
play
role
hepat
antiautophag
effect
insulin
sinc
bind
like
inhibit
g
signal
induct
upon
atz
accumul
er
might
inhibit
signal
pathway
thu
derepress
autophagi
current
cure
sever
liver
diseas
manag
option
liver
transplant
liver
failur
lifethreaten
new
therapi
target
misfold
attempt
correct
underli
genet
mutat
current
develop
export
fold
protein
er
mediat
except
case
copii
coat
vesicl
differ
genet
diseas
origin
mutat
loss
sens
missens
copii
compon
surprisingli
almost
diseas
tissuespecif
cargospecif
one
expect
fact
given
crucial
role
copii
cargo
export
er
mutat
one
copii
compon
incompat
life
least
caus
sever
diseas
effect
spread
bodi
first
explan
select
exist
differ
paralog
copii
compon
mammal
mammalian
cell
isoform
b
isoform
b
isoform
b
c
b
b
isoform
moreov
variant
alway
present
tissu
cell
henc
presenc
differ
isoform
differ
tissu
distribut
human
protein
atla
differ
cargo
specif
explain
specif
restrict
effect
observ
patholog
caus
mutant
copii
compon
knockout
ko
anim
model
mutat
human
respons
autosom
recess
diseas
craniolenticular
dysplasia
cld
rare
syndrom
manifest
larg
late
close
fontanel
calvari
hypominer
skelet
defect
hypertelor
facial
dysmorph
diseas
caus
missens
substitut
especi
osteoblast
low
level
b
isoform
suffer
lack
activ
protein
result
mutat
defect
collagen
export
intracellular
accumul
er
henc
character
dilat
cisterna
hand
mutat
caus
congenit
dyserytropoiet
anemia
type
ii
red
blood
cell
low
level
isoform
respect
face
lack
isoform
b
interestingli
ko
mice
die
soon
birth
degener
profession
secretori
tissu
pancrea
salivari
gland
gland
digest
tract
differ
phenotyp
observ
human
mice
account
speciesspecif
function
accord
crucial
role
regul
protein
export
er
copii
compon
need
upregul
differenti
program
physiolog
transform
cell
protein
factori
case
b
plasma
cell
differenti
encount
antigen
rest
b
lymphocyt
activ
becom
protein
factori
devot
immunoglobulin
product
secret
transform
impli
complet
rearrang
secretori
pathway
expect
ere
copii
compon
also
upregul
process
increas
factori
capac
fact
effect
could
even
deleteri
flux
product
exit
factori
increas
also
known
lectin
mannos
bind
protein
transmembran
protein
kda
shuttl
er
cisgolgi
consid
marker
ergic
compart
present
lumin
lectin
domain
transmembran
region
short
cytosol
domain
end
sequenc
kkff
doubl
phenylalanin
cterminu
specif
sequenc
need
interact
er
export
doubl
lysin
instead
need
interact
copi
retriev
ergicci
golgi
back
er
form
coval
dimer
hexam
via
format
disulfid
bond
level
stalk
lumin
domain
format
least
dimer
structur
need
interact
copii
compon
format
hexam
requir
exit
er
lumin
domain
recogn
high
mannos
nglycan
protein
transport
thu
receiv
correctli
fold
protein
exit
primari
qc
step
specif
calnexincalreticulin
cycl
bind
substrat
ph
calciumdepend
bind
substrat
almost
neutral
ph
er
releas
golgi
lower
ph
ph
sensit
ensur
histidin
residu
core
lectinbind
domain
thank
mechan
thought
exit
er
cargoload
come
back
empti
via
copi
vesicl
first
discov
substrat
factor
v
factor
viii
blood
coagul
cascad
mutat
fact
correl
case
combin
defici
factor
factor
autosom
recess
mild
coagul
disord
character
low
level
blood
factor
v
factor
viii
normal
common
symptom
epistaxi
menorrhagia
excess
bleed
trauma
factor
v
viii
bulki
protein
character
huge
number
nglycosyl
lack
slow
veloc
exit
er
henc
secret
factor
v
viii
presenc
howev
low
level
protein
blood
account
secret
via
bulk
flow
even
action
lectin
transport
exclud
discuss
case
account
mutat
remain
instead
character
mutat
multipl
coagul
factor
defici
protein
small
solubl
protein
interact
two
ef
handsit
import
calciumdepend
interact
cargo
mutat
caus
null
mutat
also
missens
mutat
caus
destabil
flexibl
structur
loss
interact
type
mutat
result
inabl
interact
fv
fviii
lead
diseas
onset
requir
interact
fv
fviii
use
immunolog
comparison
consid
immunoglobulin
heavi
chain
could
state
behav
light
chain
act
lectin
transport
fv
fviii
coagul
cascad
also
protein
travel
along
secretori
pathway
lysosom
enzym
cathepsin
c
z
describ
substrat
local
lysosom
reduc
absenc
lectin
mutant
unabl
exit
er
express
moreov
physic
interact
lysosom
enzym
demonstr
found
associ
yfp
complement
assay
crosslink
secret
downregul
ko
cell
vitro
vivo
studi
also
indic
substrat
complex
see
also
paragraph
intracellular
traffick
delay
cell
subject
ko
ko
femal
mice
show
lower
plasma
level
accumul
hepatocyt
enlarg
er
howev
patient
isol
show
mutat
would
interest
analyz
whether
patient
z
mutat
develop
hepat
diseas
mutat
demonstr
past
common
substrat
pair
igm
heavi
chain
downregul
fact
decreas
igm
polymer
effici
intracellular
accumul
mutant
igm
heavi
chain
lack
first
constant
domain
propos
planar
hexam
could
work
platform
igm
polymer
subunit
transport
er
golgi
compart
increas
differenti
b
lymphocyt
plasma
cell
interestingli
preliminari
unpublish
data
indic
patient
show
lower
level
igm
compar
control
anelli
sitia
peyvandi
unpublish
data
although
rang
normal
also
suggest
plasma
cell
redund
mechan
like
exist
ensur
correct
assembl
import
essenti
molecul
igm
solubl
secret
protein
promot
integrinmedi
cell
adhes
also
substrat
complex
accord
role
bind
role
secret
higher
level
recent
describ
metastasi
human
oral
cancer
could
also
gener
characterist
cell
need
increas
secretori
capac
recent
shown
also
promot
secret
transmembran
protein
gabaar
gp
glycoprotein
arenaviru
interestingli
case
interact
seem
glycanindepend
compon
qc
machineri
earli
secretori
pathway
interact
divers
array
cargo
thu
must
find
best
deal
allow
protein
exit
er
fold
protein
given
permit
leav
er
continu
journey
along
secretori
pathway
misfold
protein
instead
must
stop
redirect
proteosom
accumul
er
affect
organel
homeostasi
strategi
protect
er
proteotox
stress
condit
excess
qc
could
allow
put
function
protein
reach
final
destin
thu
lead
lossoffunct
patholog
condit
problem
might
aris
protein
given
permit
leav
er
transport
function
thu
one
hand
novel
effect
therapeut
approach
diseas
associ
defect
rout
must
direct
multipl
intracellular
target
hand
increas
current
knowledg
molecular
mechan
regul
protein
traffic
er
could
import
perspect
cure
traffick
diseas
